71MO Clinical and biomarker analyses of intratumoral CD40 agonist sotigalimab in combination with pembrolizumab in metastatic melanoma: A phase I/II trial.
Saved in:
| Title: | 71MO Clinical and biomarker analyses of intratumoral CD40 agonist sotigalimab in combination with pembrolizumab in metastatic melanoma: A phase I/II trial. |
|---|---|
| Authors: | Bentebibel, S-E.1 (AUTHOR), McGrail, D.2 (AUTHOR), Wahab, R. Abdel1 (AUTHOR), Kochat, V.3 (AUTHOR), Arslan, E.3 (AUTHOR), Pazdrak, B.1 (AUTHOR), Tahon, N.H.4 (AUTHOR), Amaria, R.N.1 (AUTHOR), Glitza, I.C.1 (AUTHOR), Patel, S.1 (AUTHOR), Wong, M.K.K.1 (AUTHOR), Tawbi, H.A.1 (AUTHOR), Mcquade, J.1 (AUTHOR), Davies, M.1 (AUTHOR), Bernatchez, C.1 (AUTHOR), Burks, J.5 (AUTHOR), Rai, K.3 (AUTHOR), Ekmekcioglu, S.1 (AUTHOR), Lizée, L.1 (AUTHOR), Diab, A.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS242-S242. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179691498 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 71MO Clinical and biomarker analyses of intratumoral CD40 agonist sotigalimab in combination with pembrolizumab in metastatic melanoma: A phase I/II trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bentebibel%2C+S-E%2E%22">Bentebibel, S-E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McGrail%2C+D%2E%22">McGrail, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wahab%2C+R%2E+Abdel%22">Wahab, R. Abdel</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kochat%2C+V%2E%22">Kochat, V.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arslan%2C+E%2E%22">Arslan, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pazdrak%2C+B%2E%22">Pazdrak, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tahon%2C+N%2EH%2E%22">Tahon, N.H.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amaria%2C+R%2EN%2E%22">Amaria, R.N.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Glitza%2C+I%2EC%2E%22">Glitza, I.C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+S%2E%22">Patel, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wong%2C+M%2EK%2EK%2E%22">Wong, M.K.K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tawbi%2C+H%2EA%2E%22">Tawbi, H.A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mcquade%2C+J%2E%22">Mcquade, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Davies%2C+M%2E%22">Davies, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bernatchez%2C+C%2E%22">Bernatchez, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burks%2C+J%2E%22">Burks, J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rai%2C+K%2E%22">Rai, K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ekmekcioglu%2C+S%2E%22">Ekmekcioglu, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lizée%2C+L%2E%22">Lizée, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Diab%2C+A%2E%22">Diab, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS242-S242. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179691498 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.079 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S242 Titles: – TitleFull: 71MO Clinical and biomarker analyses of intratumoral CD40 agonist sotigalimab in combination with pembrolizumab in metastatic melanoma: A phase I/II trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bentebibel, S-E. – PersonEntity: Name: NameFull: McGrail, D. – PersonEntity: Name: NameFull: Wahab, R. Abdel – PersonEntity: Name: NameFull: Kochat, V. – PersonEntity: Name: NameFull: Arslan, E. – PersonEntity: Name: NameFull: Pazdrak, B. – PersonEntity: Name: NameFull: Tahon, N.H. – PersonEntity: Name: NameFull: Amaria, R.N. – PersonEntity: Name: NameFull: Glitza, I.C. – PersonEntity: Name: NameFull: Patel, S. – PersonEntity: Name: NameFull: Wong, M.K.K. – PersonEntity: Name: NameFull: Tawbi, H.A. – PersonEntity: Name: NameFull: Mcquade, J. – PersonEntity: Name: NameFull: Davies, M. – PersonEntity: Name: NameFull: Bernatchez, C. – PersonEntity: Name: NameFull: Burks, J. – PersonEntity: Name: NameFull: Rai, K. – PersonEntity: Name: NameFull: Ekmekcioglu, S. – PersonEntity: Name: NameFull: Lizée, L. – PersonEntity: Name: NameFull: Diab, A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
